Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose

Drug Des Devel Ther. 2014 Sep 18:8:1467-79. doi: 10.2147/DDDT.S65561. eCollection 2014.

Abstract

Background: Mebendazole (MBZ) is an extremely insoluble and therefore poorly absorbed drug and the variable clinical results may correlate with blood concentrations. The necessity of a prolonged high dose treatment of this drug increases the risk of adverse effects.

Methods: In the present study we prepared redispersible microparticles (RDM) containing MBZ, an oral, poorly water-soluble drug, in different proportions of low-substituted hydroxypropylcellulose (L-HPC). We investigated the microparticulate structures that emerge spontaneously upon dispersion of an RDM in aqueous medium and elucidated their influence on dissolution, and also on their oral bioavailability and therapeutic efficiency using a murine model of infection with the nematode parasite Trichinella spiralis.

Results: Elevated percentages of dissolved drug were obtained with RDM at 1:2.5 and 1:5 ratios of MBZ: L-HPC. Thermal analysis showed an amorphization of MBZ in the RDM by the absence of a clear MBZ melting peak in formulations. The rapid dissolution behavior could be due to the decreased drug crystallinity, the fast dissolution time of carriers as L-HPC, together with its superior dispersibility and excellent wetting properties. RDM-1:2.5 and RDM-1:5 resulted in increased maximum plasma concentration and area(s) under the curve (AUC)0-∞ values. Likewise, after oral administration of the RDM-1:2.5 and RDM-1:5 the AUC0-∞ were 2.67- and 2.97-fold higher, respectively, compared to those of pure MBZ. Therapeutic activity, assessed on the Trichinella spiralis life cycle, showed that RDM-1:5 was the most effective in reducing the number of parasites (4.56-fold) as compared to pure MBZ, on the encysted stage.

Conclusion: THE MBZ: L-HPC RDM might be an effective way of improving oral bioavailability and therapeutic activity using low doses of MBZ (5 mg/kg), which implies a low degree of toxicity for humans.

Keywords: Trichinella spiralis; anthelmintic activity; benzimidazole carbamates; in vitro dissolution; pharmacokinetics; redispersible microparticles.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Anthelmintics / administration & dosage*
  • Anthelmintics / pharmacokinetics
  • Anthelmintics / pharmacology*
  • Anthelmintics / therapeutic use
  • Biological Availability
  • Cellulose / administration & dosage
  • Cellulose / analogs & derivatives*
  • Cellulose / chemistry
  • Cellulose / pharmacokinetics
  • Disease Models, Animal
  • Life Cycle Stages / drug effects
  • Mebendazole / administration & dosage*
  • Mebendazole / pharmacokinetics
  • Mebendazole / pharmacology*
  • Mebendazole / therapeutic use
  • Mice
  • Mice, Inbred Strains
  • Particle Size
  • Solubility
  • Surface Properties
  • Trichinella spiralis / drug effects*
  • Trichinellosis / drug therapy*

Substances

  • Anthelmintics
  • Mebendazole
  • Cellulose
  • hydroxypropylcellulose